Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.

MLA

Yoon, Suyoung, et al. “Discovery of Simplified Leucyladenylate Sulfamates as Novel Leucyl-TRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (MTORC1) Inhibitors.” Bioorganic & Medicinal Chemistry, vol. 25, no. 15, Aug. 2017, pp. 4145–52. EBSCOhost, https://doi.org/10.1016/j.bmc.2017.06.002.

APA

Yoon, S., Kim, J. H., Koh, Y., Tran, P.-T., Ann, J., Yoon, I., Jang, J., Kim, W. K., Lee, S., Lee, J., Kim, S., & Lee, J. (2017). Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors. Bioorganic & Medicinal Chemistry, 25(15), 4145–4152. https://doi.org/10.1016/j.bmc.2017.06.002

Chicago

Yoon, Suyoung, Jong Hyun Kim, Yura Koh, Phuong-Thao Tran, Jihyae Ann, Ina Yoon, Jayun Jang, et al. 2017. “Discovery of Simplified Leucyladenylate Sulfamates as Novel Leucyl-TRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (MTORC1) Inhibitors.” Bioorganic & Medicinal Chemistry 25 (15): 4145–52. doi:10.1016/j.bmc.2017.06.002.